1. Home
  2. OCS vs AAOI Comparison

OCS vs AAOI Comparison

Compare OCS & AAOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • AAOI
  • Stock Information
  • Founded
  • OCS 2003
  • AAOI 1997
  • Country
  • OCS Switzerland
  • AAOI United States
  • Employees
  • OCS N/A
  • AAOI N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • AAOI Semiconductors
  • Sector
  • OCS Health Care
  • AAOI Technology
  • Exchange
  • OCS Nasdaq
  • AAOI Nasdaq
  • Market Cap
  • OCS 689.8M
  • AAOI 707.6M
  • IPO Year
  • OCS N/A
  • AAOI 2013
  • Fundamental
  • Price
  • OCS $18.58
  • AAOI $14.67
  • Analyst Decision
  • OCS Strong Buy
  • AAOI Buy
  • Analyst Count
  • OCS 4
  • AAOI 4
  • Target Price
  • OCS $31.50
  • AAOI $25.50
  • AVG Volume (30 Days)
  • OCS 30.4K
  • AAOI 3.2M
  • Earning Date
  • OCS 05-08-2025
  • AAOI 05-08-2025
  • Dividend Yield
  • OCS N/A
  • AAOI N/A
  • EPS Growth
  • OCS N/A
  • AAOI N/A
  • EPS
  • OCS N/A
  • AAOI N/A
  • Revenue
  • OCS $847,333.00
  • AAOI $308,551,000.00
  • Revenue This Year
  • OCS $49.27
  • AAOI $113.56
  • Revenue Next Year
  • OCS $1,920.31
  • AAOI $64.07
  • P/E Ratio
  • OCS N/A
  • AAOI N/A
  • Revenue Growth
  • OCS N/A
  • AAOI 50.30
  • 52 Week Low
  • OCS $10.79
  • AAOI $6.70
  • 52 Week High
  • OCS $23.08
  • AAOI $44.50
  • Technical
  • Relative Strength Index (RSI)
  • OCS 54.68
  • AAOI 53.00
  • Support Level
  • OCS $18.01
  • AAOI $13.31
  • Resistance Level
  • OCS $19.50
  • AAOI $15.40
  • Average True Range (ATR)
  • OCS 0.77
  • AAOI 1.15
  • MACD
  • OCS 0.17
  • AAOI 0.55
  • Stochastic Oscillator
  • OCS 66.30
  • AAOI 85.52

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About AAOI Applied Optoelectronics Inc.

Applied Optoelectronics Inc is a provider of fiber-optic networking products, for four networking end-markets; internet data center, CATV, telecom, and FTTH. The Company designs and manufactures a wide range of optical communications products at varying levels of integration, from components, subassemblies, and modules to complete turn-key equipment. Through direct sales personnel, and manufacturing teams in the United States, China, and Taiwan, the company coordinates with customers to determine product design, qualifications, and performance. The Company has manufacturing and research and development facilities located in the U.S., Taiwan, and China.

Share on Social Networks: